At some point, we all want a time machine to go back in time and bring us back our youth, firm and wrinkle free skin, thicker and shinier hair, stronger joints, and the energy of the past… Well, the mechanism of natural restoration of health, youth and beauty is hidden in our own body and can be triggered by platelets containing proteins capable of stimulating cell regeneration – hence, healing us by using our own blood!
In ancient times, the healers believed that blood had magical properties and they were right. Blood is made up of an intercellular substance – plasma – and elements such as erythrocytes, leukocytes and platelets. Each of these cells has its own task: erythrocytes provide tissue respiration, leukocytes protect the body against infections, platelets are part of the blood clotting processes.
Therefore, platelets play an important role in the healing and regeneration of traumatized tissues, producing growth factors that regulate and stimulate the growth and survival of tissues. Growth factors are required for cell genesis and normal cell cycle performance. The symbiosis of growth factors is responsible for the reconstruction of blood vessels in the traumatized area, regeneration of new tissues (epithelial, cartilaginous, connective, muscular, nervous) and for stopping the bleeding.
Therefore, the solution for the regeneration and recovery of the human body is in the platelets. Autologous platelet (APT) injections naturally restore health, youth, and beauty.
This renewable source of health that resides in our own blood was developed and applied in 2003 by the Russian scientists Renat R. Akhmerov (professor, Doctor of Medicine, plastic surgeon and maxillofacial surgeon, oncodermatologist) and Roman F. Zarudy (PhD in Medical Sciences, maxillofacial surgeon, implantologist). They created the Plasmolifting™ technology, a medical procedure that can be called, without exaggeration, the “modern elixir of youth”.
Using the unique ability of growth factors (produced by the platelets) to influence regenerative processes, Akhmerov and Zarudy developed this method of injecting autologous platelet-rich plasma (PRP) into human tissues. In other words, we’re talking about autohemotherapy: immediate, intramuscular or subcutaneous, freshly extracted autologous blood injections. In PRP, the blood t is transformed into platelet plasma (by centrifugation). Applying platelet-rich plasma is the only way to improve wound repair and combat infection without the help of other drugs. The Plasmolifting™ method was used for the first time by the Russian surgeons to treat inflammatory and atrophic diseases, in the postoperative period, in maxillofacial surgery. But practice showed that the spectrum of application for this injectable therapy is much more extensive. Plasmolifting™ is a method of regenerative medicine that treats various pathologies in areas such as aesthetic medicine, gynecology, stomatology, trichology, orthopedics, traumatology, sports medicine and urology.
The Plasmolifting™ technology – this renewable source of health contained in our own blood – was developed and applied in the 21st century. Applying autologous platelet-rich plasma (PRP) began with the use of this injectable form in maxillofacial surgery. During the research, scientists discovered that, when PRP is injected into the affected areas, the acceleration of skin regeneration processes is stimulated. The skin also becomes more hydrated, more elastic, firmer, the number and depth of expression wrinkles and pigment spots is reduced.
And, despite the fact that this method was originally developed for dental purposes, this aesthetic effect led Renat R. Akhmerov and Roman F. Zarudy to continue studying the influence of platelet-rich plasma on the human body, which led to innovative discoveries concerning the use of Plasmolifting™ in the treatment of disease in different areas of medicine.
With the improvement of the method, special test tubes were also created. The chemicals and the special gel in them allow a high level of PRP purification, which significantly increases the effectiveness of the injectable treatment.
1905 : German surgeon August Bier discovered that, injected with their own blood, patients with bone fractures heal faster.
1935 – 1980:before antibiotics, autohemotherapy (intramuscular injection of a small amount of blood taken from the same individual) and autoserotherapy (treatment with blood from the patient’s blood) were among the most popular secondary treatments.
1980 : maxillofacial surgeon Robert E. Marx was the first to use blood plasma as a gel; the discovery that platelets contain protein factors (PRP factors) that stimulate cellular regeneration opened the way for the autologous plasma gel production technology; this was developed mainly for use in stomatology (the Harvest company, USA).
2003 : the Russian scientists Renat R. Akhmerov (Professor, Doctor of Medicine, plastic surgeon and maxillofacial surgeon, oncodermatologist) and Roman F. Zarudy (Doctor of Medicine, maxillofacial surgeon, implantologist) were the first in the world to use platelet-rich autologous plasma to treat inflammatory and atrophic diseases, in the postoperative period; the technology was named Plasmolifting™.
2004 : Plasmolifting ™ clinical trials were carried out on the two Russian scientists and on volunteers, to treat photodermatosis, hair loss and acne, with good results (in addition to the therapeutic effects, the patients’ skin was rejuvenated); Roman F. Zarudy explained that the new injecting form of plasma opened up new possibilities for them, as maxillofacial surgeons (especially for tissue regeneration), and the method revolutionized this sphere of surgical practice; at first, their colleagues were skeptical of his new technology’s success, but – with time – the Plasmolifting™ method began to be applied in various fields of medicine.
2011 : with the support of doctors Akhmerov and Zarudy, the Plasmolifting Company was set up; it exclusively produces and distributes the equipment necessary for the Plasmolifting™ method, wishing to offer everyone this natural healing method; today, the Plasmolifting Company has created a vast distribution network in Europe, develops and distributes the Plasmolifting™ tubes and organizes specialty courses; the aim of the company is to convert autologous plasma injections into a routine biological stimulation method.